These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 27900865

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases.
    Shinkai H.
    Vasc Health Risk Manag; 2012; 8():323-31. PubMed ID: 22661899
    [Abstract] [Full Text] [Related]

  • 3. Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.
    Mohammadpour AH, Akhlaghi F.
    Clin Pharmacokinet; 2013 Aug; 52(8):615-26. PubMed ID: 23658137
    [Abstract] [Full Text] [Related]

  • 4. Future of cholesteryl ester transfer protein inhibitors.
    Rader DJ, deGoma EM.
    Annu Rev Med; 2014 Aug; 65():385-403. PubMed ID: 24422575
    [Abstract] [Full Text] [Related]

  • 5. Cholesteryl ester transfer protein inhibitors: challenges and perspectives.
    Filippatos TD, Klouras E, Barkas F, Elisaf M.
    Expert Rev Cardiovasc Ther; 2016 Aug; 14(8):953-62. PubMed ID: 27171534
    [Abstract] [Full Text] [Related]

  • 6. Cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia: a systematic review and meta-analysis.
    Li C, Zhang W, Zhou F, Chen C, Zhou L, Li Y, Liu L, Pei F, Luo H, Hu Z, Cai J, Zeng C.
    PLoS One; 2013 Aug; 8(10):e77049. PubMed ID: 24204732
    [Abstract] [Full Text] [Related]

  • 7. On- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors.
    Johns DG, Duffy J, Fisher T, Hubbard BK, Forrest MJ.
    Drugs; 2012 Mar 05; 72(4):491-507. PubMed ID: 22356288
    [Abstract] [Full Text] [Related]

  • 8. Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib.
    Goldberg AS, Hegele RA.
    Drug Des Devel Ther; 2012 Mar 05; 6():251-9. PubMed ID: 23055695
    [Abstract] [Full Text] [Related]

  • 9. [HDL and CETP in atherogenesis].
    Pöss J, Böhm M, Laufs U.
    Dtsch Med Wochenschr; 2010 Feb 05; 135(5):188-92. PubMed ID: 20082258
    [Abstract] [Full Text] [Related]

  • 10. Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase.
    Simic B, Mocharla P, Crucet M, Osto E, Kratzer A, Stivala S, Kühnast S, Speer T, Doycheva P, Princen HM, van der Hoorn JW, Jukema JW, Giral H, Tailleux A, Landmesser U, Staels B, Lüscher TF.
    Atherosclerosis; 2017 Feb 05; 257():186-194. PubMed ID: 28152406
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CETP: Pharmacogenomics-Based Response to the CETP Inhibitor Dalcetrapib.
    Tardif JC, Rhainds D, Rhéaume E, Dubé MP.
    Arterioscler Thromb Vasc Biol; 2017 Mar 05; 37(3):396-400. PubMed ID: 28126828
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dalcetrapib: a review of Phase II data.
    Robinson JG.
    Expert Opin Investig Drugs; 2010 Jun 05; 19(6):795-805. PubMed ID: 20465364
    [Abstract] [Full Text] [Related]

  • 18. An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels.
    Rhainds D, Arsenault BJ, Brodeur MR, Tardif JC.
    Future Cardiol; 2012 Jul 05; 8(4):513-31. PubMed ID: 22871191
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The end of the road for CETP inhibitors after torcetrapib?
    Joy T, Hegele RA.
    Curr Opin Cardiol; 2009 Jul 05; 24(4):364-71. PubMed ID: 19522058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.